FGF-23 and cognitive performance in hemodialysis patients

Hemodialysis International

Volumn 18, Issue 1, 2014, Pages 78-86

  Drew, David A ^a   Tighiouart, Hocine ^b   Scott, Tammy M ^a   Lou, Kristina V ^a   Fan, Li ^a   Shaffi, Kamran ^a   Weiner, Daniel E ^a   Sarnak, J Mark ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cognition; FGF 23; Hemodialysis

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PHOSPHORUS;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MIDDLE AGED; MINERAL METABOLISM; NEUROLOGIC EXAMINATION; SEX DIFFERENCE;

COGNITION; FGF-23; HEMODIALYSIS;

ADULT; AGE FACTORS; AGED; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; SEX FACTORS;

EID: 84891902893     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12100     Document Type: Article

References (39)

1. Murray AM, Tupper DE, Knopman DS, etal. Cognitive impairment in hemodialysis patients is common. Neurology. 2006; 67:216-223.
2. Sarnak MJ, Tighiouart H, Scott TM, etal. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013; 80:471-480.
3. Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997; 30:41-49.
4. Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int Suppl. 1993; 40:S23-S27.
5. Kurella M, Mapes DL, Port FK, Chertow GM. Correlates and outcomes of dementia among dialysis patients: The dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 2006; 21:2543-2548.
6. Weiner DE, Scott TM, Giang LM, etal. Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2011; 58:773-781.
7. Tamura MK, Larive B, Unruh ML, etal. Prevalence and correlates of cognitive impairment in hemodialysis patients: The frequent hemodialysis network trials. Clin J Am Soc Nephrol. 2010; 5:1429-1438.
8. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 2003; 64:2272-2279.
9. Gutierrez OM, Januzzi JL, Isakova T, etal. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009; 119:2545-2552.
10. Kirkpantur A, Balci M, Gurbuz OA, etal. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant. 2011; 26:1346-1354.
11. Kendrick J, Cheung AK, Kaufman JS, etal. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol. 2011; 22:1913-1922.
12. Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant. 2010; 25:3983-3989.
13. Jean G, Terrat JC, Vanel T, etal. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant. 2009; 24:2792-2796.
14. Isakova T, Xie H, Yang W, etal. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011; 305:2432-2439.
15. Gutierrez OM, Mannstadt M, Isakova T, etal. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008; 359:584-592.
16. Faul C, Amaral AP, Oskouei B, etal. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011; 121:4393-4408.
17. Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun. 2000; 277:494-498.
18. Liu S, Guo R, Simpson LG, Xiao Z-S, Burnham CE, Quarles LD. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem. 2003; 278:37419-37426.
19. Yazaki N, Hosoi Y, Kawabata K, etal. Differential expression patterns of mRNAs for members of the fibroblast growth factor receptor family, FGFR-1-FGFR-4, in rat brain. J Neurosci Res. 1994; 37:445-452.
20. Emoto N, Gonzalez A-M, Walicke PA, etal. Basic fibroblast growth factor (FGF) in the central nervous system: Identification of specific loci of basic FGF expression in the rat brain. Growth Factors. 1989; 2:21-29.
21. Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol. 2007; 18:1637-1647.
22. Drew DA, Tighiouart H, Scott TM, Shaffi K, Weiner DE, Sarnak MJ. Cognitive performance before and during hemodialysis: A randomized crossover trial [Abstract]. J Am Soc Nephrol. 2012; 23:431A.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
24. Blair J, Spreen O. Predicting premorbid IQ: A revision of the national adult reading test. Clin Neuropsychol. 1989; 3:129-136.
25. Tulsky D, Zhu J, Lebetter M. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III), Wechsler Memory Scale-Third Scale (WMS-III): Technical Manual. San Antonio, TX: Harcourt Brace & Company. 1997.
26. Heaton R, Grant I, Mathews C. Comprehensive Norms for An Expanded Halstead-Reitan Battery. Odessa, TX: Psychological Assessment Resources Inc. 1991.
27. Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods. 1999; 4:272-299.
28. Gutierrez O, Isakova T, Rhee E, etal. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005; 16:2205-2215.
29. Shimada T, Yamazaki Y, Takahashi M, etal. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol. 2005; 289:F1088-F1095.
30. Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958; 26:24-36.
31. Reilly JF, Kumari VG. Alterations in fibroblast growth factor receptor expression following brain injury. Exp Neurol. 1996; 140:139-150.
32. Urakawa I, Yamazaki Y, Shimada T, etal. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006; 444:770-774.
33. Gutiérrez OM, Wolf M, Taylor EN. Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol. 2011; 6:2871-2878.
34. Viaene L, Bammens B, Meijers BKI, Vanrenterghem Y, Vanderschueren D, Evenepoel P. Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients. Nephrol Dial Transplant. 2012; 27:2017-2022.
35. Tanaka H, Hamano T, Fujii N, etal. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009; 45:949-955.
36. Wahl P, Xie H, Scialla J, etal. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care. 2012; 35:994-1001.
37. Wishart JM, Need AO, Horowitz M, Morris HA, Nordin BEC. Effect of age on bone density and bone turnover in men. Clin Endocrinol (Oxf). 1995; 42:141-146.
38. Khosla S, Atkinson EJ, Melton LJ, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study. J Clin Endocrinol Metab. 1997; 82:1522-1527.
39. Lorenzo V, Martín M, Rufino M, etal. Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis. 2001; 37:1260-1266.